FdaApplication
ANDA 212062
Identifiers
- fda_app_no: ANDA212062
Properties
| Property | Value |
|---|---|
| applicant_name | TORRENT PHARMACEUTICALS LTD |
| application_type | ANDA |
| approval_date | 2019-03-26 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TADALAFIL | TADALAFIL | 20MG | TABLET;ORAL |
| TADALAFIL | TADALAFIL | 40MG | TABLET;ORAL |
2 products